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Abstract Wnt proteins play important roles in regulating
cell differentiation, proliferation and polarity. Wnts have
been proposed to play roles in tissue repair and fibrosis, yet
the gene expression profile of fibroblasts exposed to Wnts
has not been examined. We use Affymetrix genome-wide
expression profiling to show that a 6-h treatment of fibro-
blasts of Wnt3a results in the induction of mRNAs encod-
ing known Wnt targets such as the fibrogenic pro-adhesive
molecule connective tissue growth factor (CTGF, CCN2).
Wnt3a also induces mRNAs encoding potent pro-fibrotic
proteins such as TGFβ and endothelin-1 (ET-1). Moreover,
Wnt3a promotes genes associated with cell adhesion and
migration, vasculature development, cell proliferation and
Wnt signaling. Conversely, Wnt3a suppresses gene asso-
ciated with skeletal development, matrix degradation and
cell death. Results were confirmed using real-time polymer-
ase chain reaction of cells exposed to Wnt3a and Wnt10b.
These results suggest that Wnts induce genes promoting
fibroblast differentiation towards angiogenesis and matrix
remodeling, at the expense of skeletal development.
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Introduction
Wnt signaling, a conserved molecular mechanism in ani-
mals, enables cells to converse with each other to co-
ordinate a remarkable variety of cellular processes, such as
cell fate, differentiation, cell survival and migration during
morphogenesis (Logan and Nusse 2004). Wnts can stimu-
late numerous intracellular signal transduction cascades,
including the essentially linear canonical β-catenin path-
way, which regulates gene expression, and non-canonical
pathways, which regulate many other aspects of cell
biology (Cadigan and Liu 2006). A hallmark of the
canonical Wnt pathway is the stabilization and nuclear
localization of β-catenin (Schohl and Fagotto 2002).
Without the presence of Wnts, β-catenin is targeted for
degradation, whereas the presence of Wnts results in β-
catenin stabilization and nuclear localization (Willert and
Jones 2006). There are several different Wnt proteins, often
with different overall effects on cells (Musgrove 2004).
Wnt signaling has been shown to play an essential role
in brain, limb, mammary, skin, and most recently cardio-
vascular and lung development (Morrisey 2003). Chilosi
and colleagues (2003) observed accumulation of nuclear β-
catenin, the downstream mediator of the canonical Wnt
pathway, in both epithelial and mesenchymal (myofibro-
blast) cell lineages in adult human lung and evidence of
activation of this pathway in idiopathic pulmonary fibrosis.
In this light, it has been suggested that fibroblasts isolated
from fibrotic lesions of scleroderma patients possess a so-
called ‘Wnt-signature’ (Gardner et al. 2006). However, it is
unclear what exactly a ‘Wnt signature’ is in fibroblasts, nor
if application of Wnts to fibroblasts result in the direct
activation a fibrogenic or tissue repair program in fibro-
blasts. Wnts, in particular Wnt 3a, is however known to
induce the expression of members of the CCN family of
proteins [including CTGF (CCN2) and cyr61 (CCN1)] in
mesenchymal cells (Luo et al. 2004; Si et al. 2006; Leask
and Abraham 2006). CCN proteins play key roles in matrix
remodeling, tissue repair and fibrogenesis (Leask and
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Table 1 Cluster analysis ( p<0.02) of mRNAs (out of 145 total) induced more than twofold in fibroblasts by Wnt3a treatment (6 h)
Affymetrix ID Increase Gene name
Cell cycle
1416268_at 2.266 Ets2 E26 avian leukemia oncogene 2
1422631_at 7.433 Ahr Aryl-hydrocarbon receptor
1424325_at 2.098 Esco1 Establishment of cohesion 1 homolog 1
1423250_a_at 3.321 Tgfb2 TGFbeta2
1427267_at 2.098 Zfp469 Zinc finger protein 469
1429658_a_at 2.15 Smc2 Structural maintenance of chromosomes 2
1439766_x_at 3.715 Vegfc Vascular endothelial growth factor C
1440739_at 3.275 Vegfc Vascular endothelial growth factor C
1449027_at 2.54 Rhou Ras homolog gene family, member U
1449028_at 3.193 Rhou Ras homolog gene family, member U
1450922_a_at 3.483 Tgfb2 TGFbeta2
1450923_at 3.086 Tgfb2 TGFbeta2
1452459_at 2.837 Aspm Abnormal spindle-like, microcephaly associated
1453851_a_at 4.925 Gadd45g Growth arrest and DNA-damage-inducible 45 gamma
Angiogenesis
1416039_x_at 3.067 CCN1(Cyr61) Cysteine-rich protein 61
1419417_at 3.372 Vegfc Vascular endothelial growth factor C
1423250_a_at 3.321 Tgfb2 TGFbeta2
1434025_at 2.145 Klf5 Kruppel-like factor 5
1434776_at 2.154 Sema5a Semaphorin 5A
1438133_a_at 3.229 CCN1(Cyr61) Cysteine rich protein 61
1439766_x_at 3.715 Vegfc Vascular endothelial growth factor C
1440739_at 3.275 Vegfc Vascular endothelial growth factor C
1442340_x_at 3.186 CCN1(Cyr61) Cyr61
1450922_a_at 3.483 Tgfb2 TGFbeta2
1450923_at 3.086 Tgfb2 TGFbeta2
1451021_a_at 2.227 Klf5 Kruppel-like factor 5
1451924_a_at 2.113 Edn1 Endothelin 1
1457823_at 2.908 Cyr61 Cyr61
Cytoskeleton
1417011_at 2.017 Sdc2 Syndecan 2
1425060_s_at 3.794 Rsn Restin
1428579_at 2.38 Fmnl2 Formin-like 2
1431098_at 2.668 Clip1 CAP-GLY domain containing linker protein 1
1435551_at 5.084 Fhod3 Formin homology 2 domain containing 3
1437554_at 2.382 Plec1 Plectin 1
1450650_at 2.356 Myo10 Myosin X
1455056_at 2.645 Lmo7 LIM domain only 7
Cell motility/adhesion
1418733_at 2.436 Twist1 Twist gene homolog 1
1423250_a_at 3.321 Tgfb2 TGFbeta2
1426300_at 2.559 Alcam Activated leukocyte cell adhesion molecule
1426301_at 2.572 Alcam Activated leukocyte cell adhesion molecule
1427267_at 2.098 Zfp469 Zinc finger protein 469
1437466_at 2.865 Alcam Activated leukocyte cell adhesion molecule
1434776_at 2.154 Sema5a Semaphorin 5A
1437467_at 2.846 Alcam Activated leukocyte cell adhesion molecule
1450922_a_at 3.483 Tgfb2 TGFbeta1
1450923_at 3.086 Tgfb2 TGFbeta2
1454966_at 2.161 Itga8 Integrin alpha 8
Wnt signaling
1428808_at 2.016 Prickle2 Prickle-like 2
1450044_at 2.687 Fzd7 Frizzled homolog 7
1450772_at 2.195 Wnt11 Wingless-related MMTV integration site 11
1459804_at 2.105 Crebbp CREB binding protein
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Abraham 2006). Although these results suggest that Wnts
play key roles in initiating tissue remodeling and fibrotic
expression profiles in fibroblasts, this hypothesis has not
been tested. In fact, the overall effect of Wnts on fibroblast
gene expression is wholly unknown.
In this report, we use Affymetrix gene profiling and real-
time polymerase chain reaction (PCR) analysis to identify
the transcripts induced by Wnts in NIH 3T3 fibroblasts.
Our results provide new insights into the role that Wnts
may play in fibroblast differentiation.
Materials and methods
Cell cultures NIH 3T3 fibroblasts (ATCC) were cultured in
low glucose Dulbecco’s modified Eagle’s medium
(DMEM), 10% calf serum, and antibiotic/antimycotic
solution (Invitrogen, Burlington, Ontario) at 37°C, 5%
CO2. Cells were serum starved in DMEM/0.5% calf serum
for 18 h and treated with or without Wnt3a (R and D
Systems) for additional lengths of time as indicated.
Alternatively, conditioned media obtained from cell lines
overexpressing Wnt 1, 4, 5 or 10 or containing empty
expression vector (courtesy Cun-Yu Wang, University of
Michigan) was added to DMEM/0.5% calf serum in a 1:1
ratio. RNAwas then harvested using Trizol (Invitrogen) and
quantified as previously described (Shi-wen et al. 2004,
2006; Kennedy et al. 2007).
RNA quality assessment, probe preparation and gene chip
hybridization and analysis
Microarrays and analysis were performed essentially as
previously described (Shi-wen et al. 2004; Liu et al. 2007;
Kennedy et al. 2007). All Gene Chips were processed at the
London Regional Genomics Centre (Robarts Research
Institute, London, ON; http://www.lrgc.ca). RNA was
harvested (Trizol, Invitrogen), quantified and quality
(RNA degradation and DNA contamination) was assessed
using the Agilent 2100 Bioanalyzer (Agilent, Palo Alto,
CA) and the RNA 6000 Nano kit (Caliper Life Sciences,
Mountain View, CA). Quality data was then analyzed using
the Degradometer (http://www.dnaarrays.org). Biotinylated
complimentary RNA (cRNA) was prepared from 10 μg of
total RNA as per the Affymetrix GeneChip Technical
Analysis Manual (Affymetrix, Santa Clara, CA). Double-
stranded cDNA was synthesized using SuperScript II
(Invitrogen) and oligo(dT) 24 primers. Biotin-labeled
cRNA was prepared by cDNA in vitro transcription using
the Bizarre High-Yield RNA Transcript Labeling kit (Enzo
Brioche, New York, NY) incorporating biotinylated UTP
and CTP. Fifteen µg of labeled cRNA was hybridized to
Mouse Genome 430 2.0 Gene Chips for 16 h at 45°C as
described in the Affymetrix Technical Analysis Manual
(Affymetrix, Santa Clara, CA). Gene Chips were stained
with streptavidin–phycoerythrin, followed by an antibody
solution and a second streptavidin–phycoerythrin solution,
with all liquid handling performed by a GeneChip Fluidics
Station 450 (Affymetrix). Gene Chips were scanned with
the Affymetrix GeneChip Scanner 3000 (Affymetrix).
Signal intensities for genes were generated using GCOS1.2
(Affymetrix) using default values for the Statistical Expres-
sion algorithm parameters and a target signal of 150 for all
probe sets and a normalization value of 1. Normalization
was performed in GeneSpring 7.2 (Agilent Technologies
Inc.). The RMA preprocessor was used to import data from
the.cel files. Data were first transformed, (measurements
less than 0.01 set to 0.01) and then normalized per chip to
the 50th percentile, and per gene to wild-type control
samples. Experiments were performed twice, and fold
changes were identified using the GeneSpring filter. Data
presented in Table 1 are an average of these independent
studies. The fold change between treated and untreated
samples had to be at least twofold to identify a transcript as
being altered. These criteria had to be met in both sets of
experiments. A list of the two fold changes was compiled
and exported into EASE for further analysis. These group-
Table 1 (continued)
Affymetrix ID Increase Gene name
1459804_at 2.105 Crebbp CREB binding protein
1460729_at 2.606 Rock1 Rho-associated coiled-coil containing protein kinase 1
CCN family
1438133_a_at 3.229 CCN1(Cyr61) Cysteine rich protein 61
1442340_x_at 3.186 CCN1(Cyr61) Cysteine rich protein 61
1457823_at 2.908 CCN1(Cyr61) Cysteine rich protein 61
1416953_at 2.42 CCN2 (Ctgf) Connective tissue growth factor
1448593_at 2.232 CCN4(Wisp1) WNT1 inducible signaling pathway protein 1
1419015_at 3.661 CCN5(Wisp2) WNT1 inducible signaling pathway protein 2
1448594_at 3.023 CCN4(Wisp1) WNT1 inducible signaling pathway protein 1
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Table 2 Cluster analysis ( p<0.02) of mRNAs (out of 159 total) decreased more than twofold in fibroblasts by Wnt3a treatment (6 h)
Affymetrix ID Fold decrease Gene name
Skeletal development
1418175_at 0.365 Nr1i1 Vitamin D receptor
1418176_at 0.27 Nr1i1 Vitamin D receptor
1421073_a_at 0.386 EP4 Prostaglandin E receptor 4 (subtype EP4)
1421979_at 0.33 HPDR Phosphate regulating gene (hypophosphatemia)
1423500_a_at 0.33 Sox5 SRY-box containing gene 5
1424950_at 0.206 sox9 SRY-box containing gene 9
1427277_at 0.16 Kitl Transcribed locus
1439753_x_at 0.412 Six4 Sine oculis-related homeobox 4 homolog
1440827_x_at 0.442 Sox5 SRY-box containing gene 5
1451538_at 0.437 Sox9 SRY-box containing gene 9
1456862_at 0.415 Six4 Sine oculis-related homeobox 4 homolog
Endopeptidase activity
1417109_at 0.444 Tinagl Tubulointerstitial nephritis antigen-like
1422561_at 0.457 Adamts5 Aggrecanase-2
1433434_at 0.468 AW551984 Expressed sequence AW551984
1437506_at 0.458 Adamts6 A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 6
1435697_a_at 0.455 Mmp12 Matrix metalloprotenase 12
1450716_at 0.426 Adamts1 A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 1
1450658_at 0.416 Adamts5 Aggrecanase-2
1418981_at 0.44 Casp12 Caspase 12
1421979_at 0.33 Phex Phosphate regulating gene (hypophosphatemia)
Programmed cell death
1415832_at 0.417 Agtr2 Angiotensin II receptor, type 2
1417130_s_at 0.452 Angptl4 Angiopoietin-like 4
1418981_at 0.44 Casp12 Caspase 12
1424950_at 0.206 Sox9 SRY-box containing gene 9
1426752_at 0.477 Phf17 PHD finger protein 17
1434601_at 0.498 Amigo2 Adhesion molecule with Ig like domain 2
1442884_at 0.349 Hgf Hepatocyte growth factor
1449297_at 0.446 Casp12 Caspase 12
1449033_at 0.397 Tnfrsf11b Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
1451538_at 0.437 Sox9 SRY-box containing gene 9
1451866_a_at 0.445 Hgf Hepatocyte growth factor
1452179_at 0.423 Phf17 PHD finger protein 17
1452985_at 0.452 Uaca Uveal autoantigen with coiled-coil domains and ankyrin repeats
Transcription
1418175_at 0.365 Nr1i1 Vitamin D receptor
1418176_at 0.27 Nr1i1 Vitamin D receptor
1422607_at 0.425 Etv1 Ets variant gene 1
1423233_at 0.388 Cebpd CCAAT/enhancer binding protein (C/EBP), delta
1427277_at 0.16 Kitl Kit1
1434736_at 0.416 Hlf Hepatic leukemia factor
1435828_at 0.332 Maf Musculoaponeurotic fibrosarcoma (v-maf)
1456862_at 0.415 Six4 Sine oculis-related homeobox 4 homolog
1439753_x_at 0.412 Six4 Sine oculis-related homeobox 4 homolog
1447849_s_at 0.339 Maf Musculoaponeurotic fibrosarcoma (v-maf)
1450684_at 0.356 Etv1 Ets variant gene 1
1456060_at 0.301 Maf Musculoaponeurotic fibrosarcoma (v-maf)
1416302_at 0.388 Ebf1 Early B-cell factor 1
1416301_a_at 0.493 Ebf1 Early B-cell factor 1
1439789_at 0.481 Ebf1 Early B-cell factor 1
1428349_s_at 0.432 Ebf3 Early B-cell factor 3
1440827_x_at 0.442 Sox5 SRY-box containing gene 5
1451538_at 0.437 Sox9 SRY-box containing gene 9
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ings were restricted to the GO Biological Process and
subjected to Fisher exact probability and Benjamini as the
primary statistics and multiplicity correction respectively.
These groupings had to have at least six members/
functional groupings that were part of the GO Biological
Process system (p<0.02) to be considered relevant. Note
that the list of CCN family members was compiled
independent of the cluster analysis. The relevant lists were
exported back into the affymetrix.com website to compile
the gene name and functions.
Real time RT-PCR RNAwas harvested using the Qiashredder
and RNeasy kit (Qiagen) and used for real-time RT-PCR.
Twenty-five nanograms of RNAwas reverse transcribed and
Table 2 (continued)
Affymetrix ID Fold decrease Gene name
1423500_a_at 0.33 Sox5 SRY-box containing gene 5
1424950_at 0.206 Sox9 SRY-box containing gene 9
G protein coupled receptor signaling
1415832_at 0.417 Agtr2 Angiotensin II receptor, type 2
1417625_s_at 0.282 Cxcr7 Chemokine (C-X-C motif) receptor 7
1420349_at 0.137 Ptgfr Prostaglandin F receptor
1421073_a_at 0.386 Ptger4 Prostaglandin E receptor 4 (subtype EP4)
1421470_at 0.395 Grpr Gastrin releasing peptide receptor
1425814_a_at 0.223 Calcrl Calcitonin receptor-like
1440777_x_at 0.334 Ptgfr Prostaglandin F receptor
1449828_at 0.375 Ptgfr Prostaglandin F receptor
1453924_a_at 0.16 Ptgfr Prostaglandin F receptor















































Fig. 1 Wnts 3a and 10b induce gene expression in fibroblasts. Wnt3a
induces mRNA expression in fibroblasts. NIH 3T3 fibroblasts were
treated with or without Wnt3a (150 ng/ml, 6 h). RNAs were harvested,
and subjected to real time PCR analysis to detect 18S rRNA and
RNAs as indicated. Experiments were performed thrice. A represen-
tative experiment is shown (three replicates). Variation within samples
was less than 10%. NIH 3T3 fibroblasts were also treated with or
without conditioned media prepared from cells stably transfected with
empty expression vector or vector encoding Wnt10b. RNAs were
harvested, and subjected to real time PCR analysis to detect 18S
rRNA and RNAs as indicated. Untreated or vector-alone-treated
samples are expressed as 1 (control). Experiments were performed at
least twice. A representative experiment is shown (three replicates).
CCN2, TSP-1 (thrombospondin-1), VEGF-C, PLOD2, TGFβ2 and
ET-1 transcripts were examined. Variation within samples was less
than 10%. Significance is indicated by an asterisk
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amplified using TaqMan Assays on Demand (Applied
Biosystems) in a 15-μl reaction containing primers (Assays
on Demand, Applied Biosystems) and 6-carboxyfluroscein
labeled TaqMan MGB probe. Reverse transcriptase qPCR
Mastermix (Applied Biosystems) was added to samples and
the ABI Prism 7900 HT sequence detector (Perkin–Elmer–
Cetus, Vaudreuil, QC) was used according to manufacturer’s
instructions to detect amplified sequences. Samples were run
in triplicate, transcripts were measured in picograms and
expression values were standardized to control values from
18S rRNA primers. Statistical analysis was done using one
way ANOVA and Tukey’s post hoc test on GraphPad.
Transfection assays For transfection assays, cells were
plated at a density of 25,000 cells/well in a 24 well plate.
Cells were allowed to grow for 24 h at 37°C, 5% CO2.
Cells were then transfected with polyfect (Qiagen) as
described by the manufacturer. Cells were transfected with
plasmids containing a CCN2 promoter fused to a secreted
alkaline phosphatase (SEAP) reporter gene. Cells were
transfected with 1 μg of CCN2-SEAP constructs that
contained the −805 to +17 region of the CCN2 promoter
(Abraham et al. 2000; Holmes et al 2001). Cells were
cultured for 16 h in serum-free media then treated with or
without wnts for 24 h. To control for transfection efficiency
cells were cotransfected with 0.5 μg of a cytomegalovirus
(CMV) promoter–β-galactosidase (β-gal) reporter gene
(Clontech, Palo Alto, CA, USA) construct. Promoter assays
were performed with a Phospha-Light kit (Applied Bio-
systems, Foster City, CA, USA) according to manufac-
turer’s protocol and SEAP reporter expression was adjusted
for differences in β-galactosidase expression as determined
by a Galacto-Star kit (Applied Biosystems) according to
manufacturer’s protocol. Data was expressed as average
values ± standard deviation of at least three replicates and at
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Fig. 2 Wnt 3a induces gene expression in fibroblasts. Time-course
analysis. NIH 3T3 fibroblasts were treated with or without Wnt3a
(150 ng/ml) for the time periods as indicated. RNAs were harvested,
and subjected to real time PCR analysis to detect 18S rRNA and target
RNAs as indicated. Experiments were performed twice. A represen-
tative experiment is shown (three replicates). CCN2, TSP-1 (throm-
bospondin-1), VEGF-C, PLOD2, TGFβ2 and ET-1 transcripts were


























Fig. 3 Wnt 3a induces CCN2, CCN5 and CCN3 mRNAs. NIH 3T3
fibroblasts were treated with or without Wnt3a (150 ng/ml) for the
time periods as indicated. RNAs were harvested, and subjected to real
time PCR analysis to detect 18S rRNA and target RNAs as indicated.
Experiments were performed twice. A representative experiment is
shown (three replicates). CCN2, CCN5 and CCN3 transcripts were
examined. Note that Wnt3a was less effective at inducing CCN3
mRNA than at inducing CCN2 and CCN5 mRNAs. Variation within
samples was less than 10%
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were obtained from an LMax II 384 luminometer (Molecular
Devices, Sunnyvale CA, USA) and SoftMax Pro 4.7.1
(Molecular Devices, Sunnyvale CA, USA). Levels were
measured in relative light units and were standardized to
control values from β-gal. Statistical tests were done using
one-way ANOVA and Tukey’s post hoc test on GraphPad.
Results
mRNAs whose expression are altered by exposure of NIH
3T3 fibroblasts to Wnt3a
To determine the effect of Wnts on fibroblasts, NIH 3T3
fibroblasts were incubated in serum-free media for 24 h and
exposed to Wnt3a (150 ng/ml) for 6 hours. RNAs were
extracted and subjected to Affymetrix genome-wide profil-
ing. There were 145 genes induced greater that twofold by
Wnt3a. Cluster analysis revealed that genes induced upon
Wnt treatment included those mediating angiogenesis, Wnt
signaling, cell adhesion and motility, cell proliferation and
the cytoskeleton (Table 1). These mRNAs include CCN1
and CCN2, as anticipated, but also those encoding potent
pro-differentiation/angiogenic proteins such as TGFβ2,
endothelin-1 (ET-1) and vascular endothelial growth factor,
all of which are involved with tissue remodeling and repair
(Leask and Abraham 2006; Shi-wen et al. 2004, 2006;
Tonnesen et al. 2000). Conversely, exposure of NIH 3T3
fibroblasts to Wnt3a reduced expression of 159 mRNAs in-
cluding those mediating skeletal development, cell death and
endopeptidase (matrix metalloproteinase) activity (Table 2).
These results suggest that Wnt exposure is promoting angio-
genesis at the expense of bone formation, and matrix pro-
duction and remodeling at the expense of matrix degradation.
To further investigate the role of Wnt3a in the induction
of gene expression in fibroblasts, we verified our gene
expression profiling data using real-time PCR. We showed
that a 6 h treatment of fibroblasts with Wnt3a resulted in an
induction of CCN2, ET-1, TGFβ2 and VEGF-C mRNAs
(Fig. 1). Based on these data, we also investigated whether
Wnt3a could also induce additional genes involved with
tissue remodeling and repair such as PLOD2 and thrombo-
spondin-1 (van der Slot et al. 2003; Murphy-Ullrich and
Poczatek 2000). To extend our results to other members of
the Wnt family, we exposed fibroblasts to Wnt10b for 6
hours. Wnt 10 b induced a similar set of mRNAs to Wnt3a,
although Wnt10b was not able to significantly induce
VEGF-C (Fig. 1). To further analyze the ability of Wnts to
induce gene expression in fibroblasts, fibroblasts were
exposed in the presence or absence of Wnt3a for up to
48 h. RNA was prepared and subjected to real-time PCR
analysis using appropriate primers. These mRNAs were
induced with slightly differing kinetics, but were nonethe-
less sustained over a 48 h period (Fig. 2).
Wnt3a induces CCN2 (CTGF) and CCN5
(Wisp2) and CCN3 (nov) mRNA expression in NIH
3T3 fibroblasts
Our microarray analysis revealed, as expected, that CCN
family members were induced upon Wnt3a treatment
(Table 1). Of this family, CCN1, CCN2, CCN4 and
CCN5 but not CCN3 (nov) mRNAs were detected as being
increased upon Wnt3a treatment (Table 1). Real time PCR





































Fig. 4 Wnts 1, 3a and 10b, but not Wnts 4 or 5a, induce the CCN2
promoter in fibroblasts. NIH 3T3 fibroblasts were transfected with a
CCN2 promoter/SEAP reporter construct, which contains the region
spanning from −805 to + 17 of the CCN2 promoter (Abraham et al.
2000). After a serum starvation step, cells were treated with or without
Wnt3a (150 ng/ml, 24 h) or with or without conditioned media from
cells stably transfected with empty expression vector or expression
vector encoding Wnt 1, 4, 5a or 10b (24 h). Experiments were
performed thrice. A representative experiment is shown (N=6, average ±
standard deviation is shown). Significance is indicated by an asterisk
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induced by Wnt3a, conversely CCN3 (nov) was induced
approximately 50% (Fig. 3). These results confirm our
microarray studies and indicate that CCN3 is not a potent
responder to Wnt3a in fibroblasts.
Wnts 1, 3a and 10b, but not Wnt 4 and 5a, induce
the CCN2 promoter in NIH 3T3 fibroblasts
Our Affymetrix gene profiling and real-time PCR analysis
confirmed previous results that Wnt3a induced CCN2
mRNA and protein in mesenchymal cells (Luo et al.
2004). For our studies, we considered that CCN2 was a
key target of Wnt signaling because of the role of CCN2 as
a key marker and mediator of wound healing and fibro-
genesis (Blom et al. 2002; Leask and Abraham 2006).
Accordingly, to obtain insights into the mechanism under-
lying Wnt action on fibroblasts, we investigated whether (a)
the canonical Wnts (Wnt3a and 10b) could induce the
CCN2 promoter. To perform this analysis, we transfected
NIH 3T3 fibroblasts with a CCN2 promoter/reporter
construct bearing nucleotides −805 and +17 of the promoter
(Abraham et al. 2000; Leask et al. 2003) and exposed these
cells to Wnts 3b and 10a. Wnts induced the CCN2 promoter
(Fig. 4). To further assess the mechanisms by which Wnts
act on the CCN2 promoter, we addressed whether addi-
tional Wnts could induce the CCN2 promoter. We found
that an additional canonical Wnt, Wnt1, induced the CCN2
promoter (Fig. 4). Conversely, non-canonical Wnts 4 and
5a (Kuhl et al. 2000) were not able to induce the CCN2
promoter. These data extend the notion that Wnts regulate
the CCN family, and in particular CCN2, in fibroblasts.
Discussion
Previous studies have found that Wnts are induced during
tissue remodeling and repair (Okuse et al. 2005). However,
the direct effect of Wnts on gene expression in fibroblasts
has not been ascertained until this report. Wnt addition
caused the induction of known Wnt targets such as
members of the CCN family (Luo et al. 2004; Si et al.
2006). That Wnts induced CCN1, CCN2, CCN4 and CCN5
are not surprising as these are known Wnt targets (Luo et
al. 2004; Si et al. 2006; Leask and Abraham 2006).
Canonical, but not non-canonical, Wnts activate the
CCN2 promoter; the mechanism underlying this activation
is beyond the scope of our current paper. However, it in
interesting that Wnt3a only modestly induced CCN3 (nov)
mRNA. In this regard, CCN3 was recently shown to inhibit
Wnt signaling (Rydziel et al. 2007) and thus that the lower
magnitude of CCN3 induction by Wnt3a may be expected.
Fibrotic fibroblasts have been considered to have a ‘Wnt
signature’ as revealed by cluster analysis of Affymetrix
gene profiling data (Gardner et al. 2006). However, Wnt 3a
did not cause an as potent induction of other profibrotic/
matrix remodeling genes as, say, application of TGFβ or
ET-1 to fibroblasts (Shi-wen et al. 2004, Liu et al. 2007;
Leask and Abraham 2004). For example, α-smooth muscle
actin (α-SMA) was not detected in our studies. However, in
our current report we found that Wnt3a also induced
mRNA expression of TGFβ2 and ET-1 (and indeed
CCN2). We are currently evaluating if the Wnt cascade
can induce excessive tissue remodeling/repair or fibro-
genesis through these intermediaries.
It is interesting to note that Wnts enhanced the
expression of angiogenenic and matrix remodeling genes
at the expense of genes involved with skeletal development
and in particular chondrogenesis (e.g. sox9). Previous
evidence has suggested that Wnts induce an osteogenic
lineage (in fact via CCN 1; Baron et al. 2006; Si et al.
2006). However, prior to initiating the osteogenic lineage,
chondrogenesis is required, for which the sox9 is essential
(Akiyama et al. 2005). Our results are therefore in good
agreement with recent data that physical and functional
interactions exist between β-catenin and Sox9. In vivo,
either overexpression of Sox9 or inactivation of β-catenin
in chondrocytes of mouse embryos produces a similar
phenotype of dwarfism with decreased chondrocyte prolif-
eration, delayed hypertrophic chondrocyte differentiation,
and endochondral bone formation (Akiyama et al. 2004).
Moreover, Sox9 inhibits activation of β-catenin-dependent
promoters and stimulates degradation of β-catenin
(Akiyama et al. 2004), suggesting that chondrogenesis is
controlled by interactions between Sox9 and the Wnt/β-
catenin signaling pathway. Moreover, it is also intriguing
that Wnt3a induced pro-mitotic mRNAs yet suppressed
pro-apoptotic mRNAs. These results are consistent with
recent observations that Wnt3a promotes proliferation of
mesenchymal stem cells (Baksh and Tuan 2007). Collec-
tively, our data support the notion that Wnts are potent
modulators of fibroblast differentiation.
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